Previous studies have confirmed that SLC25A51 is significantly overexpressed in human hepatocellular carcinoma (HCC) and enhances glycolysis and HCC progression by activating sirtuin 5 (SIRT5) [121]. The gene discussed is SLC25A51; the disease is hepatocellular carcinoma.